SCHEMBL15525577

SCHEMBL15525577

CP(O)(=S)OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]c(N)nc32)C[C@@H]1O

nearest known ligand 0.74

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.74
▸ P2RY2 P41231 1/20 0.62
▸ P2RY4 P51582 1/20 0.62
▸ P2RY6 Q15077 1/20 0.62
▸ NT5E P21589 2/20 0.54
▸ FUT5 Q11128 1/20 0.51
▸ TGM2 P21980 1/20 0.51
▸ TAS1R3 Q7RTX0 2/20 0.48
▸ TAS1R1 Q7RTX1 2/20 0.48
▸ KRAS P01116 2/20 0.48
▸ TYMP P19971 1/20 0.48
▸ HINT1 P49773 1/20 0.48
▸ F2 P00734 1/20 0.48
▸ ENPP1 P22413 1/20 0.47
▸ P2RY1 P47900 1/20 0.47
▸ IMPDH2 P12268 1/20 0.47
▸ IMPDH1 P20839 1/20 0.47
▸ DTYMK P23919 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24059956 0.93 POLB (0.77) POLBP2RY2P2RY4P2RY6NT5E
SCHEMBL20276932 0.93 POLB (0.77) POLBP2RY2P2RY4P2RY6NT5E
SCHEMBL6917413 0.93 POLB (0.77) POLBP2RY2P2RY4P2RY6NT5E
SCHEMBL20282863 0.93 POLB (0.77) POLBP2RY2P2RY4P2RY6NT5E
SCHEMBL20277563 0.93 POLB (0.77) POLBP2RY2P2RY4P2RY6NT5E
SCHEMBL503124 0.92 POLB (0.78) POLBP2RY2P2RY4P2RY6NT5E
SCHEMBL48232 0.91 POLB (0.82) POLBP2RY2P2RY4P2RY6NT5E
SCHEMBL25171429 0.91 POLB (0.82) POLBP2RY2P2RY4P2RY6NT5E
SCHEMBL1971161 0.91 POLB (0.82) POLBP2RY2P2RY4P2RY6NT5E
SCHEMBL16678590 0.91 POLB (0.82) POLBP2RY2P2RY4P2RY6NT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200239884-A1 METHODS OF TREATING DIABETES AND/OR PROMOTING SURVIVAL OF PANCREATIC ISLETS AFTER TRANSPLANTATION UNIV MIAMI (US) 2020-07-30 — — US disclosed
US-10443056-B2 Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation NOGRA PHARMA LIMITED (IE) 2019-10-15 — — US disclosed
EP-2839004-B1 METHODS OF TREATING DIABETES AND/OR PROMOTING SURVIVAL OF PANCREATIC ISLETS AFTER TRANSPLANTATION NOGRA PHARMA LTD (IE) 2019-06-12 — — EP disclosed
US-20190136237-A1 METHODS OF TREATING DIABETES AND/OR PROMOTING SURVIVAL OF PANCREATIC ISLETS AFTER TRANSPLANTATION NOGRA PHARMA LIMITED (IE) 2019-05-09 — — US disclosed
US-20190100758-A1 Methods of Treating Colorectal Cancer NOGRA PHARMA LTD (IE) 2019-04-04 — — US disclosed
US-10081809-B2 Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation UNIVERSITY OF MIAMI (US) 2018-09-25 — — US disclosed
US-10006029-B2 Methods of treating colorectal cancer NOGRA PHARMA LIMITED (IE) 2018-06-26 — — US disclosed
EP-2970419-B1 METHODS OF TREATING COLORECTAL CANCER NOGRA PHARMA LTD (IE) 2018-05-09 — — EP disclosed
CN-107252492-A The method survived after treatment diabetes and/or promotion pancreatic islets transplantation 诺格尔制药有限公司 2017-10-17 — — CN disclosed
CN-104487574-B Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation 诺格尔制药有限公司 2017-07-07 — — CN disclosed
EP-2970419-A1 METHODS OF TREATING COLORECTAL CANCER Nogra Pharma Limited (IE) 2016-01-20 — — EP disclosed
US-20150315573-A1 METHODS OF TREATING DIABETES AND/OR PROMOTING SURVIVAL OF PANCREATIC ISLETS AFTER TRANSPLANTATION UNIVERSITY OF MIAMI (US) 2015-11-05 — — US disclosed
EP-2839004-A1 METHODS OF TREATING DIABETES AND/OR PROMOTING SURVIVAL OF PANCREATIC ISLETS AFTER TRANSPLANTATION Nogra Pharma Limited (IE) 2015-02-25 — — EP disclosed
US-20140271860-A1 Methods of Treating Colorectal Cancer NOGRA PHARMA LIMITED (IE) 2014-09-18 — — US disclosed
WO-2014140333-A1 METHODS OF TREATING COLORECTAL CANCER NOGRA PHARMA LIMITED (IE) 2014-09-18 — — WO disclosed
WO-2013158868-A1 METHODS OF TREATING DIABETES AND/OR PROMOTING SURVIVAL OF PANCREATIC ISLETS AFTER TRANSPLANTATION NOGRA PHARMA LIMITED (IE) 2013-10-24 — — WO disclosed
Send feedback